Loss of LYN Is Frequent in Targeted Therapy-Resistant Melanoma Cells and Favors Metastatic Properties.
Gaudel C, Pisibon C, Soysouvanh F, Giuliano S, Picard-Gauci A, Leclerc J, Hofman P, Bahadoran P, Bertolotto C, Ballotti R.
Gaudel C, et al. Among authors: giuliano s.
J Invest Dermatol. 2024 Jul 20:S0022-202X(24)01913-4. doi: 10.1016/j.jid.2024.06.1286. Online ahead of print.
J Invest Dermatol. 2024.
PMID: 39033988
Free article.
No abstract available.